 MYOS RENS Technology, Inc. MYOS NASDAQ: MYOS, an advanced nutrition company and the owner of Fortetropin, a proprietary bioactive composition that helps build lean muscle, and MedAvail, Inc. MedAvail, a private, in-clinic telemedicine-enabled pharmacy organization that has developed and commercialized a proprietary robotic dispensing platform and home delivery operation focused on the Medicare Advantage market in the United States, or U.S, announced today that they have entered into a definitive Agreement and Plan of Merger and Reorganization the Merger Agreement in which a wholly-owned subsidiary of MYOS will merge with and into MedAvail, with MedAvail being the surviving corporation and a wholly-owned subsidiary of MYOS the Merger. 